Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,625 | 453 | 41.4% |
| Education | $6,196 | 16 | 29.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 2 | 10.8% |
| Travel and Lodging | $2,241 | 10 | 10.8% |
| Consulting Fee | $1,500 | 1 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $6,742 | 17 | $0 (2023) |
| Minerva Surgical, Inc | $5,146 | 7 | $0 (2019) |
| PFIZER INC. | $852.21 | 51 | $0 (2024) |
| ABBVIE INC. | $750.27 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $624.62 | 24 | $0 (2024) |
| Applied Medical Resources Corporation | $560.24 | 1 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $459.23 | 31 | $0 (2022) |
| TherapeuticsMD, Inc. | $436.27 | 30 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $420.69 | 18 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $339.41 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $907.02 | 45 | MAYNE PHARMA COMMERCIAL LLC ($314.27) |
| 2023 | $1,006 | 42 | Astellas Pharma US Inc ($272.64) |
| 2022 | $883.98 | 50 | PFIZER INC. ($171.68) |
| 2021 | $1,886 | 64 | COLOPLAST CORP ($1,001) |
| 2020 | $1,360 | 50 | Coloplast Corp ($360.44) |
| 2019 | $3,568 | 72 | Minerva Surgical, Inc ($1,599) |
| 2018 | $10,095 | 91 | Coloplast Corp ($4,616) |
| 2017 | $1,105 | 68 | PFIZER INC. ($189.79) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 10/28/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $0.83 | General |
| 09/23/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: HORMONE THERAPY | ||||||
| 08/29/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 08/14/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $10.70 | General |
| 07/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: HORMONE THERAPY | ||||||
| 07/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.88 | General |
| 06/27/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: HORMONE THERAPY | ||||||
| 06/26/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.81 | General |
| 06/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: UROLOGY | ||||||
| 06/13/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Womens Health | ||||||
| 05/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 05/07/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 05/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $5.96 | General |
| 05/02/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 769 | 4,725 | $54,968 | $29,223 |
| 2022 | 10 | 710 | 15,778 | $52,996 | $27,374 |
| 2021 | 12 | 767 | 16,595 | $60,264 | $30,915 |
| 2020 | 11 | 688 | 11,843 | $53,305 | $25,434 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 185 | $19,278 | $10,523 | 54.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 122 | 122 | $5,490 | $4,760 | 86.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 118 | 118 | $7,145 | $4,198 | 58.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $5,930 | $3,294 | 55.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 180 | 180 | $4,320 | $3,184 | 73.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 169 | $6,084 | $1,522 | 25.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 15 | 17 | $3,230 | $1,421 | 44.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 36 | 165 | $2,475 | $175.08 | 7.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $276.00 | $78.43 | 28.4% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 23 | 3,701 | $740.20 | $67.82 | 9.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 212 | $21,680 | $12,151 | 56.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 106 | 106 | $6,490 | $3,926 | 60.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 178 | 178 | $4,272 | $3,171 | 74.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 76 | 76 | $3,420 | $3,037 | 88.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $2,990 | $1,610 | 53.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 171 | $6,156 | $1,566 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $2,190 | $1,336 | 61.0% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 31 | 14,801 | $2,960 | $272.28 | 9.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 34 | 162 | $2,430 | $189.04 | 7.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 34 | $408.00 | $117.06 | 28.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 182 | 202 | $20,604 | $12,051 | 58.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 139 | 139 | $8,390 | $5,090 | 60.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 183 | 183 | $4,392 | $3,267 | 74.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 65 | 65 | $2,925 | $2,594 | 88.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 22 | $3,212 | $1,872 | 58.3% |
About Dr. Marshall Shoemaker, MD
Dr. Marshall Shoemaker, MD is a Obstetrics & Gynecology healthcare provider based in Fairhope, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659321065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Shoemaker, MD has received a total of $20,812 in payments from pharmaceutical and medical device companies, with $907.02 received in 2024. These payments were reported across 482 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($8,625).
As a Medicare-enrolled provider, Shoemaker has provided services to 2,934 Medicare beneficiaries, totaling 48,941 services with total Medicare billing of $112,947. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Fairhope, AL
- Active Since 05/10/2006
- Last Updated 04/22/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1659321065
Products in Payments
- ALTIS (Device) $5,346
- Endometrial Ablation System (Device) (Device) $5,146
- Altis (Device) $1,001
- PREMARIN (Drug) $613.45
- GELPORT (Device) $560.24
- NASCOBAL (Drug) $459.23
- FEMALE INCONTINENCE (Device) $360.44
- GEMTESA (Drug) $322.46
- Saxenda (Drug) $268.04
- Kyleena (Drug) $248.17
- CONTRAVE (Drug) $239.23
- MYFEMBREE (Drug) $221.95
- UBRELVY (Drug) $217.07
- Osphena (Drug) $203.71
- IMVEXXY (Drug) $198.94
- Orilissa (Drug) $196.29
- Dayvigo (Drug) $188.69
- ANNOVERA (Drug) $187.87
- LO LOESTRIN FE (Drug) $176.36
- PREMARIN ORALS (Drug) $170.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Fairhope
Angela Mccool-Pearson, M.d, M.D
Obstetrics & Gynecology — Payments: $58,882
Mary Wells, Md, MD
Obstetrics & Gynecology — Payments: $6,424
Dr. Leslie Evans, Md, MD
Obstetrics & Gynecology — Payments: $5,606
Gary Nelson, Md, MD
Obstetrics & Gynecology — Payments: $5,282
Jennifer Lambert, Crnp, CRNP
Obstetrics & Gynecology — Payments: $4,514
Dylan Wells, Md, MD
Obstetrics & Gynecology — Payments: $4,440